These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7150772)

  • 1. [Activation of the membrane toxicity and cytotoxicity of the tumor cell by leukocyte and fibroblast interferon].
    Sterlina AG; Malinovskaia VV; Bogdashin IV; Fuks BB
    Biull Eksp Biol Med; 1982 Dec; 94(12):80-2. PubMed ID: 7150772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of the cytotoxic effect of tumor cells against the targets of normal killers].
    Fuks BB; Zedginidze MS; Spirande IV; Kogarko IN; Sterlina AG
    Biull Eksp Biol Med; 1981 Sep; 92(9):342-5. PubMed ID: 7295991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous cytotoxicity of murine cells treated with the interferon inducers BRL 5907 and BRL 10739.
    Cook RM
    Immunology; 1980 Feb; 39(2):151-7. PubMed ID: 7380465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of membrane antigens on 141 (NZB) and EL4 (C57BL) lymphoma cells as demonstrated by antibody-induced resistance to complement-mediated cytotoxicity.
    Ran M; Yaakubowicz M; Talal N; Witz IP
    Eur J Immunol; 1978 Jun; 8(6):423-8. PubMed ID: 78855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Membranotoxicity of tumor cells to lymphocytes. Role of homology for IC-subregion of H2-complex].
    Sterlina AG; Nikonenko BV; Fuks BB
    Biull Eksp Biol Med; 1982 Jan; 93(1):52-5. PubMed ID: 6978160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
    Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
    J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of anti-tumor antibody in progressive tumor growth.
    Manson LA
    Transplant Proc; 1984 Apr; 16(2):524-7. PubMed ID: 6426105
    [No Abstract]   [Full Text] [Related]  

  • 11. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
    Chen L; McGowan P; Ashe S; Johnston JV; Hellström I; Hellström KE
    Cancer Res; 1994 Oct; 54(20):5420-3. PubMed ID: 7522958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of irradiation on the cellular sensitivity of separate NKLy tumor subpopulations to the membrane-toxic action of natural killers].
    Slivinskiĭ GG; Krifuks OI; Magda IN
    Radiobiologiia; 1989; 29(4):564-6. PubMed ID: 2780993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells.
    Przepiorka D; Mokyr MB; Dray S
    Cancer Res; 1980 Dec; 40(12):4565-70. PubMed ID: 7438090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
    Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of x-rays on the sensitivity of cells of the murine NKLy tumor to the membrane toxic effect of natural killers].
    Slivinskiĭ GG; Krifuks OI; Magda IN
    Radiobiologiia; 1987; 27(6):789-93. PubMed ID: 3423232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice.
    Sun T; Kim TS; Waltz MR; Cohen EP
    Cancer Gene Ther; 1995 Sep; 2(3):183-90. PubMed ID: 8528961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimetastatic effect of CpG DNA mediated by type I IFN.
    Hafner M; Zawatzky R; Hirtreiter C; Buurman WA; Echtenacher B; Hehlgans T; Männel DN
    Cancer Res; 2001 Jul; 61(14):5523-8. PubMed ID: 11454702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced in vitro macrophage cytotoxicity against interferon-treated B16 melanoma cells.
    Fleischmann CM; Fleischmann WR
    J Biol Regul Homeost Agents; 1995; 9(4):139-45. PubMed ID: 8844338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
    Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
    Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
    Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.